---
title: "Picard Medical soars 41% in regular trading after Q2 revenue beats"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296820374.md"
description: "Picard Medical surged 41% to $4.53 after Q2 revenue rose 39% to $2.95 million, beating estimates, with net loss narrowing 16%."
datetime: "2026-08-24T18:51:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296820374.md)
  - [en](https://longbridge.com/en/news/296820374.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296820374.md)
generator: "portal-rs"
---

# Picard Medical soars 41% in regular trading after Q2 revenue beats

Picard Medical(PMI.US) 盘中涨 41.12%，现报 4.53 美元。

公司 Q2 营收同比增长 39% 至 295 万美元，超出分析师预期，净亏损收窄 16%。公司推进 Emperor Total Artificial Heart 人工心脏项目研发，并完成反向拆股操作。

### Related Stocks

- [PMI.US](https://longbridge.com/en/quote/PMI.US.md)

## Related News & Research

- [Picard Medical presents preliminary Emperor total artificial heart architecture at IEEE EMBC 2026](https://longbridge.com/en/news/294509888.md)
- [PMI: Revenue up 50% but net loss widens; going concern risk persists amid heavy R&D investment](https://longbridge.com/en/news/296403475.md)
- [01:00 ETWorld-first International Standard launched as demand grows for better workplace support during menstruation and menopause](https://longbridge.com/en/news/298167577.md)
- [Picard Medical, Inc. 1Q 2026: Revenue $1.15M, EPS ($0.1) — 10-Q Summary](https://longbridge.com/en/news/286604148.md)
- [Picard Medical, Inc. 2026: Revenue $2.95M, EPS ($3.05) — 10-Q Summary](https://longbridge.com/en/news/296404089.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**